Edition:
India

Mediwound Ltd (MDWD.OQ)

MDWD.OQ on NASDAQ Stock Exchange Global Market

5.25USD
20 Apr 2018
Change (% chg)

$0.10 (+1.94%)
Prev Close
$5.15
Open
$5.10
Day's High
$5.30
Day's Low
$5.10
Volume
4,855
Avg. Vol
6,158
52-wk High
$8.25
52-wk Low
$3.60

Chart for

About

MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's product, NexoBrid, is indicated for the removal of dead... (more)

Overall

Beta: 0.04
Market Cap(Mil.): $135.72
Shares Outstanding(Mil.): 26.35
Dividend: --
Yield (%): --

Financials

  MDWD.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -0.75 -- --
ROI: -52.80 14.84 14.38
ROE: -240.59 16.34 16.07

BRIEF-MediWound Q3 loss per share $0.49

* Q3 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S

16 Nov 2017

BRIEF-Tel Aviv district court ordered Mediwound to purchase about $1.5 mln of PolyHeal shares

* Tel Aviv district court ordered Mediwound to purchase approximately $1.5 million of PolyHeal shares; Mediwound weighing an appeal

14 Nov 2017

BRIEF-MediWound appoints Mr. Stephen T. Wills as chairman

* MediWound appoints Mr. Stephen T. Wills as chairman to its Board of Directors

25 Oct 2017

Earnings vs. Estimates